Year: 2019
Type: article
Abstract: Radical cystectomy (RC) is the gold standard treatment and most effective method for local control of muscle invasive and high risk, non-invasive bladder cancer (1,2). RC is, unfortunately, a major surgery with significant attendant morbidity. Notwithstanding improvements in surgical technique and pre-, peri-, and postoperative care, 27–64% of patients experience at least one complication with a 26–43% 90-day readmission rate and a 1.5–3% 30-day mortality rate (3-6). These numbers also bespeak the relative frailty and poor baseline physiologic reserve of patients frequently in consideration for RC. Thus, the decision to proceed with surgery should involve a careful and thoughtful weighing of risks to benefits as well as a thorough discussion with the patient on their individualized risks.
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2940299254